Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Mawer Investment Management Ltd. BNT Brookfield Wealth Solutions Ltd. 13G/A 7.82% 2y
BlackRock Inc. VERI Veritone, Inc. 13G/A 4.8% 2y
BlackRock Inc. CDIO Cardio Diagnostics Holdings, Inc. 13G/A 4.9% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 3.7% 2y
BlackRock Inc. RELY Remitly Global, Inc. 13G/A 4.97% 2y
BlackRock Inc. FVCB FVCBankcorp, Inc. 13G/A 4.96% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 38.9% 2y
BlackRock Inc. BRBS Blue Ridge Bankshares, Inc. 13G/A 4.8% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 0% 2y
BlackRock Inc. DQ Daqo New Energy Corp. 13G/A 10.6% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 0% 2y
BlackRock Inc. KD Kyndryl Holdings, Inc. 13G/A 10% 2y
BlackRock Inc. PDSB PDS Biotechnology Corp 13G/A 4.96% 2y
Ansari Mohammad Jawad ZONE Zone Frontier Inc. 13D 21.45% 2y
BlackRock Inc. VTNR Vertex Energy, Inc 13G/A 4.96% 2y
BlackRock Inc. ITIC Investors Title Co 13G/A 4.6% 2y
BlackRock Inc. VFC V F Corp 13G/A 10.8% 2y
Mitchell P. Kopin TFFP TFF Pharmaceuticals, Inc. Common Stock 13G 4.99% 2y
IA Venture Strategies Fund II, LP DOCN DigitalOcean Holdings, Inc. 13G/A 3.26% 2y
Novartis Pharma AG PSTX Poseida Therapeutics, Inc. Common Stock 13G/A 0% 2y
SIT INVESTMENT ASSOCIATES INC PPT Franklin Premier Income Trust 13D/A 19.94% 2y
SIT INVESTMENT ASSOCIATES INC VTN Invesco Trust for Investment Grade New York Municipals 13D/A 9.55% 2y
L. John Doerr AMRS Amyris Inc. 13D/A 0% 2y
AKIN THOMAS B USAU U.S. Gold Corp. 13G 5.8% 2y
SHAH CAPITAL MANAGEMENT NVAX Novavax Inc 13D/A 7.7% 2y
Bertelsmann SE & Co. KGaA AFYA Afya Ltd 13D/A 61.3% 2y
CoyCo GP, L.L.C. RCM R1 RCM Inc. Common Stock 13D/A 32.3% 2y
Carvana Group, LLC ROOT Root, Inc. 13D/A 44.5% 2y
Forager Fund, L.P. RM Regional Management Corp. 13G/A 11% 2y
CPMG Inc PRCT PROCEPT BioRobotics Corp 13D/A 7.4% 2y
Legion Partners Asset Management, LLC OSPN OneSpan Inc. 13D/A 8.2% 2y
Nathan D. Hukill TTOO T2 Biosystems, Inc 13D/A 65.4% 2y
BW Group Limited DHT DHT Holdings, Inc. 13D/A 12.7% 2y
David B. Blundin EVER EverQuote, Inc. 13D/A 23.2% 2y
FAIRHOLME CAPITAL MANAGEMENT LLC JOE ST JOE Co 13D/A 37.8% 2y
MILLENNIUM MANAGEMENT LLC ANG-PD American National Group Inc. 13G 0% 2y
Sculptor Capital LP CCIX Churchill Capital Corp IX 13G 5.96% 2y
Oasis Management Co Ltd. APLD Applied Digital Corp. 13D 5.78% 2y
Affinity Asset Advisors, LLC CLYM Climb Bio, Inc. 13G 6.02% 2y
ROYCE & ASSOCIATES LP LAKE Lakeland Industries Inc 13G/A 10.15% 2y
Jianping Kong NA Nano Labs Ltd 13D/A 32.8% 2y
Pui Chun Wong KPEA Kun Peng International Ltd. 13D 53% 2y
Splendid Vibe Limited NCI Neo-Concept International Group Holdings Ltd 13D 81.5% 2y
Savant Capital, LLC DCOR Dimensional ETF Trust 13G 6.35% 2y
KNIGHT THERAPEUTICS INC. SXTP 60 Degrees Pharmaceuticals, Inc. 13G/A 9.97% 2y
Element Ventures LP RDZN Roadzen Inc. 13G 11.2% 2y
PRIOR CORNELIUS B JR ATNI ATN International, Inc. 13D 29.4% 2y
Damian Novak AMZE Amaze Holdings, Inc. 13D/A 0% 2y
Kungpeng TJ Limited KPEA Kun Peng International Ltd. 13D 16.44% 2y
Daniel R. Tisch BNED Barnes & Noble Education, Inc. 13G/A 0.3% 2y